In addition to the system, BrainDragon has three other products that have obtained regulatory approval in China, namely the Basic Cognitive Ability Test Software BCAT, the Cognitive Ability Screening Assessment Software SAS, and the Dyslexia Screening Assessment Software DSS. Another product has received regulatory approval in the European Union i., software for the treatment of cognitive dysfunction and six product candidates are in various stages of preclinical and clinical development or registration process, demonstrating the company's strong capabilities and continuous innovation in product research and development.
It can be seen that BrainAurora has laid a solid foundation for israel phone number list its longterm development in the field of digital therapy with its leading technology, rich product lines and continuous innovative R&D capabilities.
Of course, to transform pipeline advantages into actual commercial value, a key point lies in the company's commercial deployment capabilities. In this regard, BrainDong Aurora has received strong support and recognition at the national level, providing solid backing for its commercialization process.
According to Frost & Sullivan, BrainDong Aurora is the first organizer of the project initiated by the National Health Commission. In this project, the company is tasked with assisting more than , public hospitals across the country in establishing cognitive centers and promoting the development of China's digital therapeutics market for cognitive impairment.